Product Information
CEFEPIME HCL 1 GM VIAL is a generic product labeled by WG Critical Care, LLC, priced at $3.7308 per EA under NDC 44567024010. Its NADAC has been published 178 times since Jan 22, 2014.
FDA first approved this application on Mar 20, 2008. Its Orange Book therapeutic-equivalence code is AP.
Strength
1 g/20mL
Manufacturer
WG Critical Care, LLCNDC
44567024010
Classification
Generic
Dosage Form
INJECTION, POWDER, FOR SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
8/20/2025
Active Ingredients
CEFEPIME HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA065441FDA Approved
3/20/2008
TE Code
AP
On Market Since
10/10/2014
Pharmacological Classes
Price Statistics
The NADAC for CEFEPIME HCL 1 GM VIAL has been published 178 times since Jan 22, 2014, and over the history we have for it it has declined 34.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.7308 per EA |
|---|---|
| All-time high | $5.6658 (Feb 11, 2015) |
| All-time low | $3.3241 (Apr 23, 2025) |
| 52-week high | $3.7308 |
| 52-week low | $3.7308 |
| Median price | $3.7308 |
| Average price | $4.2828 |
| Largest weekly change | -36.3% (Apr 17, 2024) |
| Weeks tracked | 178 |
| Tracking since | Jan 22, 2014 |
1W
N/A
1M
N/A
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
-34.2%
5Y
-34.2%
All
-34.2%
Last surveyed Aug 12, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
WG Critical Care, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Cefepime market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cephalosporin Antibacterial class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CEFEPIME HCL 1 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CEFEPIME HCL 1 GM VIAL, manufactured by WG Critical Care, LLC, is $3.7308 per EA (NDC 44567024010), effective Aug 12, 2026.
How has the price of CEFEPIME HCL 1 GM VIAL changed over time?
Over the history we have for it, the NADAC for CEFEPIME HCL 1 GM VIAL has declined 34.2%. It has been tracked across 178 weekly CMS publications since Jan 22, 2014.
What are the highest and lowest recorded NADAC prices for CEFEPIME HCL 1 GM VIAL?
Since Jan 22, 2014, the NADAC for CEFEPIME HCL 1 GM VIAL has ranged from a low of $3.3241 (Apr 23, 2025) to a high of $5.6658 (Feb 11, 2015), with a median of $3.7308 per EA.
Are there cheaper alternatives to CEFEPIME HCL 1 GM VIAL?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFEPIME HCL 1 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures CEFEPIME HCL 1 GM VIAL?
CEFEPIME HCL 1 GM VIAL (NDC 44567024010) is labeled by WG Critical Care, LLC, and CMS classifies it as a generic product.